SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs informs about disclosure

02 May 2023 Evaluate
Aarti Drugs has informed that it is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. 

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

380.80 4.40 (1.17%)
23-Jun-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1866.05
Dr. Reddys Lab 1304.60
Cipla 1426.90
Zydus Lifesciences 1096.30
Lupin 2353.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: